Group 1 - China Metallurgical Group Corporation (China MCC) experienced a stock price increase of 5.71%, reaching 3.70 CNY per share, with a trading volume of 346 million CNY and a turnover rate of 0.54%, resulting in a total market capitalization of 76.677 billion CNY [1] - The company, established on December 1, 2008, and listed on September 21, 2009, is primarily engaged in engineering contracting (90.83% of revenue), resource development, equipment manufacturing, real estate development, and other businesses [1] Group 2 - Zhejiang Merchants Securities Asset Management has a fund that heavily invests in China MCC, specifically the Zhejiang Huijin Quantitative Selected Stock A (011824), which held 329,600 shares in the second quarter, unchanged from the previous period, accounting for 0.77% of the fund's net value [2] - The fund has achieved a year-to-date return of 27.72%, ranking 2064 out of 4220 in its category, and a one-year return of 45.12%, ranking 1512 out of 3846 [2] Group 3 - The fund manager of Zhejiang Huijin Quantitative Selected Stock A is Chen Gujun, who has been in the position for 5 years and 255 days, with the fund's total asset size at 204 million CNY [3] - During Chen Gujun's tenure, the best fund return was 37.16%, while the worst return was -7.57% [3]

Group 1 - The core viewpoint of the news is that Yingke Medical has seen a significant increase in its stock price, rising by 5.33% to 38.76 CNY per share, with a trading volume of 444 million CNY and a turnover rate of 2.54%, resulting in a total market capitalization of 25.38 billion CNY [1] - Yingke Medical, established on July 20, 2009, and listed on July 21, 2017, operates in three main business segments: personal protection (91.47% of revenue), rehabilitation care (4.75%), and other products (3.77%) [1] - The company is located in Zibo City, Shandong Province, and has its Hong Kong office at 40/F, Sunshine Center, 248 Queen's Road East, Wanchai [1] Group 2 - From the perspective of fund holdings, a fund under Zheshang Securities Asset Management has a significant position in Yingke Medical, with Zheshang Huijin Quantitative Selected Stocks A (011824) holding 40,200 shares, accounting for 0.75% of the fund's net value, making it the second-largest holding [2] - The fund has achieved a year-to-date return of 27.29%, ranking 2094 out of 4220 in its category, and a one-year return of 58.4%, ranking 1473 out of 3824 [2] - The fund manager, Chen Gujun, has been in position for 5 years and 251 days, with the fund's total asset size at 204 million CNY and a best return of 35.77% during his tenure [3]

Group 1 - China Metallurgical Group Corporation (China MCC) experienced a 2.08% decline in stock price, reaching 3.30 CNY per share, with a trading volume of 262 million CNY and a turnover rate of 0.44%, resulting in a total market capitalization of 68.388 billion CNY [1] - The stock price of China MCC has fallen for four consecutive days, with a cumulative decline of 5.44% during this period [1] - China MCC was established on December 1, 2008, and listed on September 21, 2009, with its main business activities including engineering contracting (90.83% of revenue), resource development, equipment manufacturing, real estate development, and other services [1] Group 2 - Zhejiang Merchants Securities Asset Management has a fund that heavily invests in China MCC, specifically the Zhejiang Huijin Quantitative Selected Stock A fund, which held 329,600 shares in the second quarter, unchanged from the previous period, accounting for 0.77% of the fund's net value [2] - The fund has incurred a floating loss of approximately 23,100 CNY today, with a total floating loss of 62,600 CNY during the four-day decline [2] - The Zhejiang Huijin Quantitative Selected Stock A fund was established on July 1, 2021, with a current scale of 63.808 million CNY, and has achieved a year-to-date return of 26.45% [2]

Group 1 - The core point of the news is that Jianlong Micro-Nano has seen a stock price increase of 5.31%, reaching 34.14 CNY per share, with a total market capitalization of 3.416 billion CNY [1] - Jianlong Micro-Nano, established on July 27, 1998, specializes in the research, production, sales, and technical services of molecular sieve adsorbents and catalysts in various fields including medical oxygen, energy chemistry, environmental protection, energy-saving building materials, and refrigeration systems [1] - The company's main revenue composition includes 95.36% from molecular sieve materials, 2.82% from activated alumina, and 1.82% from other sources [1] Group 2 - From the perspective of fund holdings, one fund under Zheshang Securities Asset Management has Jianlong Micro-Nano as a significant investment, holding 32,200 shares, which accounts for 0.73% of the fund's net value [2] - The Zheshang Huijin Quantitative Selected Stock A fund has achieved a year-to-date return of 23.52% and a one-year return of 58.88%, ranking 1698 out of 4222 and 1287 out of 3789 in its category, respectively [2] - The fund manager, Chen Gujun, has been in position for 5 years and 229 days, with the fund's total asset size at 204 million CNY [3]